BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 1532475)

  • 1. Frequency of the common fragile site at Xq27.2 under conditions of thymidylate stress: implications for cytogenetic diagnosis of the fragile-X syndrome.
    Ramos FJ; Emanuel BS; Spinner NB
    Am J Med Genet; 1992 Apr; 42(6):835-8. PubMed ID: 1532475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of fragile X expression in normal males for the nature of the mutation.
    Ledbetter DH; Ledbetter SA; Nussbaum RL
    Nature; 1986 Nov 13-19; 324(6093):161-3. PubMed ID: 3785381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of fragile site on the human X chromosome in somatic cell hybrids between human fragile X cells and thymidylate synthase-negative mouse mutant cells.
    Hori T; Ayusawa D; Glover TW; Seno T
    Jpn J Cancer Res; 1985 Oct; 76(10):977-83. PubMed ID: 3935628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal fragile site expression in dogs: I. Breed specific differences.
    Stone DM; Jacky PB; Hancock DD; Prieur DJ
    Am J Med Genet; 1991 Aug; 40(2):214-22. PubMed ID: 1910263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytogenetic studies in fragile X syndrome].
    Nowicki GA
    Pol Tyg Lek; 1992 Mar 2-9; 47(9-10):211-4. PubMed ID: 1437821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome lesions which could be interpreted as "fragile sites" on the distal end of Xq.
    Butler MG; Allen GA; Haynes JL; Clark SJ
    Am J Med Genet; 1990 Oct; 37(2):250-3. PubMed ID: 2248293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate and acetyl-carnitine inhibit the cytogenetic expression of the fragile X in vitro.
    Pomponi MG; Neri G
    Am J Med Genet; 1994 Jul; 51(4):447-50. PubMed ID: 7943015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic guidelines for fragile X studies tested in routine practice.
    Dewald GW; Buckley DD; Spurbeck JL; Jalal SM
    Am J Med Genet; 1992 Dec; 44(6):816-21. PubMed ID: 1481854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of fragile X syndrome in a sample from Spanish Basque country.
    Arrieta I; Criado B; Martinez B; Telez M; NuƱez T; PeƱagarikano O; Ortega B; Lostao CM
    Ann Genet; 1999; 42(4):197-201. PubMed ID: 10674158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA studies of X-linked mental retardation associated with a fragile site at Xq27.3.
    Goonewardena P; Dahl N; Gustavson KH; Holmgren G; Pettersson U
    Ups J Med Sci Suppl; 1987; 44():155-64. PubMed ID: 2895524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variations in the presence of a fragile site on X--fra(X)--according to cases and methods used].
    Crippa L; Delozier-Blanchet CD; Engel E
    J Genet Hum; 1984 Jul; 32(3):193-7. PubMed ID: 6481341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE.
    Parrish JE; Oostra BA; Verkerk AJ; Richards CS; Reynolds J; Spikes AS; Shaffer LG; Nelson DL
    Nat Genet; 1994 Nov; 8(3):229-35. PubMed ID: 7874164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fra(X)(q27.2), the common fragile site, observed in only one of 760 cases studied for the fragile X syndrome.
    Jenkins EC; Genovese MJ; Duncan CJ; Gu H; Stark-Houck SL; Lele K; Li SY; Krawczun MS
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):136-41. PubMed ID: 1605182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess thymidine induces folate sensitive fragile sites.
    Sutherland GR; Baker E; Fratini A
    Am J Med Genet; 1985 Oct; 22(2):433-43. PubMed ID: 4050872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifolate-induced misincorporation of deoxyuridine monophosphate into DNA by cells from patients with the fragile X syndrome.
    Wang JC; Beardsley GP; Erbe RW
    Am J Med Genet; 1985 Aug; 21(4):691-6. PubMed ID: 2992271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fragile X syndrome I: familial variation in the proportion of lymphocytes with the fragile site in males.
    Soudek D; Partington MW; Lawson JS
    Am J Med Genet; 1984 Jan; 17(1):241-52. PubMed ID: 6711598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of the fragile X syndrome.
    Tsongalis GJ; Silverman LM
    Arch Pathol Lab Med; 1993 Nov; 117(11):1121-5. PubMed ID: 8239933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of chromosomal abnormalities in patients referred for fragile X analysis.
    Mark HF; Bier JA; Scola P
    Ann Clin Lab Sci; 1996; 26(4):323-8. PubMed ID: 8800432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile X syndrome.
    Laxova R
    Adv Pediatr; 1994; 41():305-42. PubMed ID: 7992687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of fragile X syndrome among selected patients at Songklanagarind Hospital during 1991-1996, studied by cytogenetic and molecular methods.
    Jinorose U; Vasiknanonte P; Limprasert P; Brown WT; Panich V
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():69-74. PubMed ID: 9640603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.